BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35315858)

  • 1. Cubosomes as an emerging platform for drug delivery: a review of the state of the art.
    Abourehab MAS; Ansari MJ; Singh A; Hassan A; Abdelgawad MA; Shrivastav P; Abualsoud BM; Amaral LS; Pramanik S
    J Mater Chem B; 2022 Apr; 10(15):2781-2819. PubMed ID: 35315858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cubosomes: remarkable drug delivery potential.
    Karami Z; Hamidi M
    Drug Discov Today; 2016 May; 21(5):789-801. PubMed ID: 26780385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cubosomes in Drug Delivery-A Comprehensive Review on Its Structural Components, Preparation Techniques and Therapeutic Applications.
    Sivadasan D; Sultan MH; Alqahtani SS; Javed S
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cubosomes: Innovative Nanostructures for Drug Delivery.
    Duttagupta AS; Chaudhary HM; Jadhav KR; Kadam VJ
    Curr Drug Deliv; 2016; 13(4):482-93. PubMed ID: 25707403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured cubosomes as advanced drug delivery system.
    Pan X; Han K; Peng X; Yang Z; Qin L; Zhu C; Huang X; Shi X; Dian L; Lu M; Wu C
    Curr Pharm Des; 2013; 19(35):6290-7. PubMed ID: 23470001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cubosomes and Hexosomes as Novel Nanocarriers for Bioactive Compounds.
    Tan C; Hosseini SF; Jafari SM
    J Agric Food Chem; 2022 Feb; 70(5):1423-1437. PubMed ID: 35089018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cubosomes as versatile lipid nanocarriers for neurological disorder therapeutics: a comprehensive review.
    A Vahab S; Nair A; Raj D; G P A; P P S; S Kumar V
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3729-3746. PubMed ID: 38095651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cubosomes: Versatile Nanosized Formulation for Efficient Delivery of Therapeutics.
    Singhal K; Kaushik N; Kumar A
    Curr Drug Deliv; 2022; 19(6):644-657. PubMed ID: 34238187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioimaging Applications of Non-Lamellar Liquid Crystalline Nanoparticles.
    Murgia S; Biffi S; Fornasier M; Lippolis V; Picci G; Caltagirone C
    J Nanosci Nanotechnol; 2021 May; 21(5):2742-2759. PubMed ID: 33653441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Update on the Recent Advances in Cubosome: A Novel Drug Delivery System.
    Garg M; Goyal A; Kumari S
    Curr Drug Metab; 2021; 22(6):441-450. PubMed ID: 33402079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cubosome: A Potential Liquid Crystalline Carrier System.
    Sharma P; Dhawan S; Nanda S
    Curr Pharm Des; 2020; 26(27):3300-3316. PubMed ID: 32552637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cubosome-based nanoplatforms in cancer therapy: Seeking new paradigms for cancer theranostics.
    Gowda BHJ; Ahmed MG; Alshehri SA; Wahab S; Vora LK; Singh Thakur RR; Kesharwani P
    Environ Res; 2023 Nov; 237(Pt 1):116894. PubMed ID: 37586450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytantriol based smart nano-carriers for drug delivery applications.
    Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
    Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.
    Chountoulesi M; Pispas S; Tseti IK; Demetzos C
    Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiphilic brush polymers produced using the RAFT polymerisation method stabilise and reduce the cell cytotoxicity of lipid lyotropic liquid crystalline nanoparticles.
    Zhai J; Suryadinata R; Luan B; Tran N; Hinton TM; Ratcliffe J; Hao X; Drummond CJ
    Faraday Discuss; 2016 Oct; 191():545-563. PubMed ID: 27453499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short review on the applicability and use of cubosomes as nanocarriers.
    Palma AS; Casadei BR; Lotierzo MC; de Castro RD; Barbosa LRS
    Biophys Rev; 2023 Aug; 15(4):553-567. PubMed ID: 37681099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel RAFT amphiphilic brush copolymer steric stabilisers for cubosomes: poly(octadecyl acrylate)-block-poly(polyethylene glycol methyl ether acrylate).
    Chong JY; Mulet X; Postma A; Keddie DJ; Waddington LJ; Boyd BJ; Drummond CJ
    Soft Matter; 2014 Sep; 10(35):6666-76. PubMed ID: 25058647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer Cubosomes: Infinite Cubic Mazes and Possibilities.
    Ha S; La Y; Kim KT
    Acc Chem Res; 2020 Mar; 53(3):620-631. PubMed ID: 31920073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the study of lipid-based cubic liquid crystalline nanoparticles as drug delivery system].
    Wu HB; Huo DF; Jiang XG
    Yao Xue Xue Bao; 2008 May; 43(5):450-5. PubMed ID: 18717329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cubosomes as targeted drug delivery systems - a biopharmaceutical approach.
    Lakshmi NM; Yalavarthi PR; Vadlamudi HC; Thanniru J; Yaga G; K H
    Curr Drug Discov Technol; 2014; 11(3):181-8. PubMed ID: 24836404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.